Severe edema and blood blisters of the lower extremities caused by sitagliptin, a dipeptidyl peptidase-4 inhibitor

被引:0
|
作者
Maita, Hiroki [1 ]
Kobayashi, Tadashi [2 ]
Akimoto, Takashi [2 ]
Osawa, Hiroshi [2 ]
Kato, Hiroyuki [1 ,2 ,3 ]
机构
[1] Hirosaki Univ, Dev Community Healthcare, Grad Sch Med, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan
[2] Hirosaki Univ, Dept Gen Med, Sch Med Hosp, Aomori, Japan
[3] Hirosaki Univ, Gen Med, Grad Sch Med, Aomori, Japan
来源
JOURNAL OF GENERAL AND FAMILY MEDICINE | 2022年 / 23卷 / 02期
关键词
blister; dipeptidyl peptidase-4 inhibitor; edema; sitagliptin;
D O I
10.1002/jgf2.502
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:124 / 125
页数:2
相关论文
共 50 条
  • [1] The effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on gentamicin nephrotoxicity in mice
    Al Suleimani, Yousuf M.
    Abdelrahman, Aly M.
    Karaca, Turan
    Manoj, Priyadarsini
    Ashique, Mohammed
    Nemmar, Abderrahim
    Ali, Badreldin H.
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 97 : 1102 - 1108
  • [2] Absolute bioavailability of sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteers
    Bergman, Arthur
    Ebel, David
    Liu, Fang
    Stone, Julie
    Wang, Amy
    Zeng, Wei
    Chen, Li
    Dilzer, Stacy
    Lasseter, Kenneth
    Herman, Gary
    Wagner, John
    Krishna, Rajesh
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2007, 28 (06) : 315 - 322
  • [3] Stereoselective Synthesis of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, (R)-Sitagliptin
    Anjibabu, Ramisetti
    Boggu, Jagan Mohan Reddy
    Shekhar, Putta
    Reddy, Basi V. Subba
    CHEMISTRYSELECT, 2016, 1 (17): : 5445 - 5447
  • [4] Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension
    Mistry, Goutam C.
    Maes, Andrea L.
    Lasseter, Kenneth C.
    Davies, Michael J.
    Gottesdiener, Keith M.
    Wagner, John A.
    Herman, Gary A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (05): : 592 - 598
  • [5] Dipeptidyl peptidase-4 inhibitor approaches
    Bloomgarden, Zachary
    JOURNAL OF DIABETES, 2017, 9 (01) : 5 - 7
  • [6] Impact of Systemic Dipeptidyl Peptidase-4 Inhibitor Use in Diabetic Macular Edema
    Rahimy, Ehsan
    Baker, Keith
    Thompson, Desmond
    Saroj, Namrata
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2020, 51 (04): : 226 - 234
  • [7] Dipeptidyl peptidase-4 inhibitor sitagliptin induces vasorelaxation via the activation of Kv channels and PKA
    Li, Hongliang
    Seo, Mi Seon
    An, Jin Ryeol
    Jung, Hee Seok
    Ha, Kwon-Soo
    Han, Eun-Taek
    Hong, Seok-Ho
    Bae, Young Min
    Na, Sung Hun
    Park, Won Sun
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2019, 384
  • [8] Sitagliptin, an dipeptidyl peptidase-4 inhibitor, does not alter the pharmacokinetics of the sulphonylurea, glyburide, in healthy subjects
    Mistry, Goutam C.
    Bergman, Arthur J.
    Zheng, Wei
    Hreniuk, David
    Zinny, Miguel A.
    Gottesdiener, Keith M.
    Wagner, John A.
    Herman, Gary A.
    Ruddy, Marcella
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (01) : 36 - 42
  • [9] Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Decreases Systolic Blood Pressure in Japanese Hypertensive Patients with Type 2 Diabetes
    Ogawa, Susumu
    Ishiki, Mikihito
    Nako, Kazuhiro
    Okamura, Masashi
    Senda, Miho
    Mori, Takefumi
    Ito, Sadayoshi
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 223 (02): : 133 - 135
  • [10] Dipeptidyl Peptidase-4 Inhibitor Alarms: Is Heart Failure Caused by a Class Effect?
    Lee, Yong-ho
    DIABETES & METABOLISM JOURNAL, 2015, 39 (03) : 204 - 206